Liquidia Corporation Common Stock (LQDA) is a publicly traded Healthcare sector company. As of July 23, 2026, LQDA trades at $87.56 with a market cap of $7.19B and a P/E ratio of 359.27. LQDA moved +7.85% today. Year to date, LQDA is +152.36%; over the trailing twelve months it is +424.34%. Its 52-week range spans $10.37 to $89.51. Analyst consensus is strong buy with an average price target of $75.14. Rallies surfaces LQDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LQDA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $87.56 |
| Market Cap | $7.19B |
| P/E Ratio | 359.27 |
| EPS | $0.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.51 |
| 52-Week Low | $10.37 |
| Volume | 3.14M |
| Avg Volume | 0 |
| Revenue (TTM) | $288.06M |
| Net Income | $22.30M |
| Gross Margin | 0.00% |
8 analysts cover LQDA: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $75.14.